The activated partial thromboplastin time (aPTT) is the number of seconds plasma takes to clot through the intrinsic and common pathways, including factors XII, XI, IX, VIII, X, V, prothrombin and fibrinogen. It does not test factor VII. The aPTT is the classic test for adjusting an unfractionated heparin infusion. It is also ordered to work up bleeding, and to look for hemophilia or lupus anticoagulant.
Checked against the sources below November 2026
Normal range
Test
US units
SI units
Notes
aPTT
25–35 seconds
25–35 seconds
Therapeutic on heparin 1.5–2 times control (label; many texts 1.5–2.5), or anti-Xa per protocol
Adult ranges. Ranges differ a little between laboratories; use the range printed on your lab’s report. All coagulation values
aPTT in the ICU
Argatroban for HIT is also followed with the aPTT, but its label target is 1.5 to 3 times the baseline and not above 100 seconds, checked 2 hours after starting and after each rate change.
Before argatroban starts, the label calls for stopping heparin and getting a baseline aPTT, so later results can be compared with the client's own value.
Clients with moderate or severe liver impairment clear argatroban slowly; expect a lower starting rate and closer aPTT checks.
In DIC the aPTT can mislead dosing of direct thrombin inhibitors; a HIT review notes that aPTT-guided dosing can leave these clients underdosed.
Per the heparin label, HIT can begin anywhere from 2 to 20 days after heparin starts (average 5 to 9) and even weeks after it stops; a platelet count below 100,000/mm³ calls for stopping heparin and testing for HIT.
Prolonged aPTT
On a heparin infusion the label target is 1.5 to 2 times normal; many texts use 1.5 to 2.5, and many hospitals use an anti-Xa protocol instead. Off heparin, a long aPTT means a factor is low, blocked or consumed.
Causes
Unfractionated heparin, the most tested cause
Hemophilia A (factor VIII) or B (factor IX)
Liver disease
Vitamin K deficiency
Disseminated intravascular coagulation (DIC)
Direct thrombin inhibitors such as argatroban and bivalirudin, and direct oral anticoagulants
Lupus anticoagulant, which lengthens the test but raises clot risk in the body
Signs and symptoms
Oozing from IV, line and incision sites
Bruising, hematoma or bleeding gums
Blood in urine or stool
Deep bleeding into joints or muscle, typical of hemophilia
An unexplained drop in hematocrit or blood pressure, which can mean hidden bleeding
Nursing actions
Check the aPTT against the heparin protocol and adjust the infusion only per the protocol and order
Hold or reduce the heparin infusion per protocol when the aPTT is above range, and report it
Assess for bleeding at lines and incisions, and in urine, stool and emesis
Report a fall in hematocrit or blood pressure at once and anticipate a check for hidden bleeding
Anticipate an order for protamine for serious bleeding or overdose, and have resuscitation equipment ready
Monitor the platelet count on heparin and report a large fall
Teach the client to report bleeding gums, black stools and blood in urine
Drawing and reading the sample
Heparin in the sample, such as from a heparin-flushed line, falsely prolongs the result; follow facility policy on where to draw
During a heparin infusion the aPTT is checked about every 4 hours at first, then at set intervals per protocol
Get a baseline aPTT, INR and platelet count before starting a heparin infusion
A long aPTT that does not correct when mixed 1:1 with normal plasma points to an inhibitor, not a factor deficiency
On the exam
Heparin is followed with the aPTT; warfarin is followed with the INR
The antidote for heparin is protamine sulfate
A platelet fall of more than half on heparin suggests HIT; report it and anticipate an order to stop all heparin
A long aPTT with a normal PT and platelet count in a client with joint bleeding suggests hemophilia
Check yourself: 3 questions
Question 1 · Coagulation & Hematology
A patient with NSTEMI on a weight-based heparin infusion has a 6-hour aPTT of 118 seconds (target 60–80 seconds). The unit's nomogram includes a 1-hour hold for values above 100 seconds. There is no bleeding, and hemoglobin is stable. Which action is MOST appropriate?
hold 1 hour, then restart at the same rate.
hold 1 hour, then restart at a lower rate.
stop heparin and recheck the aPTT tomorrow.
give protamine to reverse the excess heparin.
Show the answer and rationale
Answer: B
A. Tempting because it follows the hold step exactly, but the rate that produced an aPTT of 118 seconds will drive it back above target, so nomograms also lower the rate.
B.Correct. For a markedly high aPTT without bleeding, heparin nomograms hold the infusion briefly, restart it at a reduced rate and recheck the aPTT in 6 hours.
C. Tempting because it looks cautious, but stopping for a day leaves a patient with active ACS unprotected.
D. Tempting because the aPTT is far above target, but protamine is for severe bleeding or urgent surgery; heparin's short half-life lets a hold correct the level.
Unfractionated heparin has a short half-life, so a level well above target falls quickly once the infusion is held. Hospitals titrate with an aPTT nomogram tailored to their reagent; in the ACCP example nomogram, an aPTT above the top band means hold 1 hour, then decrease the infusion by 3 units/kg/hr. The aPTT is rechecked 6 hours after each change and every 6 hours until two consecutive values are therapeutic, then daily. The nurse also checks for bleeding, the pump settings and the dosing weight. Protamine is kept for severe bleeding or surgery.
A patient receiving IV unfractionated heparin for pulmonary embolism has needed more than 35,000 units/day for 48 hours without reaching the target aPTT. Platelets are stable at 240,000/mm³. Antithrombin activity is 42% (low). Which explanation is MOST likely?
A lupus anticoagulant falsely shortening the aPTT
Vitamin K deficiency limiting the heparin response
Antithrombin deficiency, which heparin needs to work
Heparin-induced thrombocytopenia causing drug resistance
Show the answer and rationale
Answer: C
A. A lupus anticoagulant prolongs the baseline aPTT rather than shortening it.
B. Vitamin K affects warfarin and clotting factor synthesis, not heparin’s mechanism.
C.Correct. Heparin works by enhancing antithrombin, so low antithrombin blunts its effect.
D. HIT causes a falling platelet count and thrombosis. It does not cause heparin resistance with stable platelets.
Unfractionated heparin binds antithrombin and speeds its inactivation of thrombin (IIa) and factor Xa by about 1,000-fold. Heparin resistance can result from antithrombin deficiency (congenital, consumption, or from prior heparin use), high levels of factor VIII or fibrinogen (acute phase reactants), or increased heparin clearance. Options include monitoring by anti-Xa level rather than aPTT, antithrombin supplementation, or switching to a direct thrombin inhibitor.
On day 3 of VA-ECMO on heparin, a patient has aPTT 96 seconds (target 60–80) and anti-Xa 0.22 IU/mL (target 0.3–0.7). INR is 2.1 from hepatic congestion; plasma free hemoglobin and bilirubin are normal. Which interpretation is MOST accurate?
both results confirm the dose is adequate.
the anti-Xa better reflects heparin effect.
heparin is supratherapeutic and should be held.
the anti-Xa is falsely low from hemolysis.
Show the answer and rationale
Answer: B
A. Neither value sits in its target range, and they point in opposite directions, so the dose cannot be called adequate.
B.Correct. The aPTT is prolonged by the factor deficit behind the INR of 2.1, while the anti-Xa measures heparin activity, which is below target.
C. Reading the long aPTT alone suggests too much heparin, but liver-related factor deficiency lengthens the aPTT without more heparin effect.
D. Hemolysis and high bilirubin can falsely lower chromogenic anti-Xa results, but both are normal here, so the result can be trusted.
The aPTT measures the whole intrinsic clotting pathway, so liver disease, vitamin K deficiency or warfarin, lupus anticoagulant and hemolysis can prolong it without any change in heparin effect. The anti-Xa assay measures heparin's functional inhibition of factor Xa and is less affected by those conditions, although its chromogenic method can read falsely low with hemolysis, hyperbilirubinemia or high triglycerides. In mechanical circulatory support, aPTT and anti-Xa disagree in most paired samples, usually with the aPTT higher. With interference excluded, the anti-Xa of 0.22 IU/mL shows subtherapeutic heparin; ELSO's 2021 guideline uses a 0.3 to 0.7 IU/mL anti-Xa range, so the nurse reports for protocol titration.
Reference range: MedlinePlus Medical Encyclopedia ranges (National Library of Medicine, reviewed 2024–2026); ABIM laboratory reference ranges (January 2026) for hemoglobin, hematocrit and potassium; Merck Manual for ionized calcium; the heparin label for the aPTT target; ASHP/IDSA 2020 vancomycin guideline
For education and exam preparation only. Reference ranges and critical values vary by laboratory. Follow your facility’s policy and the prescriber’s orders.